Devices

Device investigations, not a drug trial with the labels changed.

ISO 14155 clinical investigations, accountability, adverse device effects, and EU vigilance beside US medical device reporting.

The device record

A device study tracks the investigation plan, the sites, the unique device identifier, and what happened to each unit. Deficiencies and adverse device effects use the device vocabulary, not a reused drug form. EU MDR vigilance and US 21 CFR 803 reports can be prepared from the same case. Post-market follow-up stays in the same organization when the study is done and the surveillance begins.

Bring us the protocol.

CAREPOI reads the study, configures ValidTrials, and the sites work in one record. The first conversation is about your protocol, not a software tour.

Request a conversation